バイオ原料の市場規模、シェア、成長分析：製品タイプ別、発現システム別、地域別 - 産業予測 2025～2032年

バイオ原料の世界市場規模は、2023年に21億9,000万米ドルと評価され、2024年の23億9,000万米ドルから2032年には47億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.0％で成長する見通しです。

世界のバイオ原料市場は、医薬品、農業、食品生産などの分野にわたる持続可能で革新的なソリューションに対する需要の高まりによって、大きな成長を遂げています。最近のバイオテクノロジー、特に遺伝子工学と合成生物学の進歩により、バイオベースの成分、酵素、化学物質が急増しており、環境面で有利でありながら性能も向上しています。さらに、資源不足や気候変動といった問題に取り組むバイオ原料の可能性に対する意識の高まりが、その採用を加速させています。とはいえ、規制上の課題や一般市民の認識は、市場の将来的なダイナミクスを形成する上で引き続き重要な役割を担っています。全体として、バイオ原料の継続的な進化と受容は、様々な産業における市場のさらなる拡大と影響力を位置づけています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 特許分析

バイオ原料市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 革新的なバイオテクノロジーAPI
• バイオシミラー

バイオ原料市場規模：製品別& CAGR（2025-2032）

• 市場概要
• モノクローナル抗体
• ワクチン
• ホルモンと成長因子
• サイトカイン
• 融合タンパク質
• 治療用酵素
• 血液因子

バイオ原料市場規模：発現システム別& CAGR（2025-2032）

• 市場概要
• 哺乳類発現システム
• 微生物発現システム
• 酵母発現システム
• 植物発現システム
• 昆虫発現システム

バイオ原料市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Novo Nordisk（Denmark）
• BASF（Germany）
• Lonza Group（Switzerland）
• DSM（Netherlands）
• Evonik Industries（Germany）
• WuXi AppTec（China）
• Samsung Biologics（South Korea）
• Biocon（India）
• Dr. Reddy's Laboratories（India）
• Divi's Laboratories（India）
• Laurus Labs（India）
• Concord Biotech（India）
• Amgen（USA）
• Genentech（USA）
• Regeneron Pharmaceuticals（USA）
• Gilead Sciences（USA）
• Celgene（USA）
• Bristol Myers Squibb（USA）
• Sanofi（France）
• GlaxoSmithKline（UK）

結論と推奨事項

Global Biotech Ingredients Market size was valued at USD 2.19 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 4.76 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global biotech ingredients market is experiencing significant growth, driven by rising demand for sustainable and innovative solutions across sectors like pharmaceuticals, agriculture, and food production. Recent advancements in biotechnology, particularly genetic engineering and synthetic biology, have led to a surge in bio-based ingredients, enzymes, and chemicals that enhance performance while providing environmental advantages. Moreover, increasing awareness of biotech ingredients' potential to tackle issues such as resource scarcity and climate change is accelerating their adoption. Nonetheless, regulatory challenges and public perception continue to play crucial roles in shaping the market's future dynamics. Overall, the continued evolution and acceptance of biotech ingredients position the market for further expansion and influence in various industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is significantly propelled by the increasing demand for sustainable and plant-based products. As consumer awareness surrounding health and environmental issues rises, there is a notable trend toward the preference for products enriched with natural and eco-friendly components. Biotechnology enables the production of these ingredients through innovative processes that are both efficient and environmentally sustainable, minimizing the dependence on conventional agricultural practices. This alignment with consumer desires for clean labels and transparency is driving the widespread adoption of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals, further boosting market growth.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable restraints primarily due to regulatory hurdles and public apprehension regarding genetically modified organisms (GMOs). Although biotechnology has made significant strides, lingering concerns about the safety of GMOs, their potential environmental repercussions, and ethical implications contribute to consumer skepticism and increased scrutiny from regulatory authorities. Stringent regulations and mandatory labeling for products incorporating biotech ingredients can hinder the market's expansion. To navigate these challenges effectively, it is essential for industry participants to pursue transparent communication, undertake thorough safety evaluations, and implement educational initiatives aimed at building consumer trust and dispelling misconceptions surrounding biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing robust growth as it adapts to shifting consumer preferences towards sustainability and natural offerings. This trend is predominantly fueled by an increasing demand for biotech-derived ingredients across diverse sectors such as food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing techniques are paving the way for the development of novel ingredients with enhanced functionalities, thereby broadening application scopes. Supportive regulatory frameworks are bolstering biotech innovation, while strategic collaborations between biotech companies and conventional manufacturers are seamlessly integrating these ingredients into mainstream products. The landscape is increasingly characterized by a pronounced pivot towards bio-based solutions that resonate with environmentally aware consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2025-2032)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2025-2032)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations